JP Morgan Cazenove Keeps The “Overweight” Rating They’ve had for BTG PLC (LON:BTG) Shares


BTG PLC (LON:BTG) Rating Reaffirmed

The rating of BTG PLC (LON:BTG) shares were reaffirmed by research professionals at JP Morgan Cazenove. This was announced in a very recent research note on 15 December.

From a total of 6 analysts covering BTG PLC (LON:BTG) stock, 4 rate it a ”Buy”, 0 a “Sell”, and 2 a ”Hold”. This means that 67% of the ratings are positive. The highest target price is GBX 1100 while the lowest target price is GBX 550. The mean of all analyst targets is GBX 771 with a 23.66% above today’s (GBX 623.5) stock price. BTG PLC was the topic of 26 analyst reports since August 6, 2015 according to the firm StockzIntelligence Inc. Deutsche Bank maintained shares on December 14 with “Buy” rating. Stifel Nicolaus maintained shares with “Sell” rating and GBX 550 target share price in a report from an October 6. Jefferies maintained BTG stock in a recent report from November 12 with “Buy” rating. Finally, Panmure Gordon maintained the stock with “Buy” rating in a report issued on a November 10.

The stock closed the day at GBX 623.5 during the previous session. It is down 20.37% since May 18, 2015 and is downtrending. It has underperformed by 15.95% the S&P500.

JP Morgan Cazenove Keeps The

BTG plc is a specialist healthcare company. The company has a market cap of 2.39 billion GBP. The Firm operates in three business divisions: Interventional Medicine (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from licensed assets). It has 53.21 P/E ratio. The Company’s Interventional Medicine segment offers a portfolio of interventional medicine products that are designed to advance the treatment of liver tumors, advanced emphysema, severe blood clots and varicose veins.

According to Zacks Investment Research, “B2Gold Corp. is involved in the exploration and development of gold. The company’s assets are situated in Nicaragua, Colombia, Namibia and Uruguay. B2Gold Corp. is headquartered in Vancouver, Canada.”